Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbalip.2013.07.007PMID 23872476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease

  2012cited by this paper
• Prebeta-1 HDL and coronary heart disease

  2012cited by this paper
• Reconstituted HDL in acute coronary syndromes.

  2012cited by this paper
• The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.

  2011cited by this paper
• The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

  2010cited by this paper
• Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport[S]

  2010cited by this paper
• Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

  2009cited by this paper
• Major lipids, apolipoproteins, and risk of vascular disease.

  2009cited by this paper
• HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.

  2008cited by this paper
• Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules

  2007cited by this paper
• HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

  2007cited by this paper
• cAMP-induced expression of ABCA1 is associated with MAP-kinase-pathway activation.

  2007cited by this paper
• Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

  2004cited by this paper
• Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200

  2004cited by this paper
• Analytical performance of a sandwich enzyme immunoassay for pre beta 1-HDL in stabilized plasma.

  2003cited by this paper
• A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans.

  2002cited by this paper
• Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

  2001cited by this paper
• A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

  2000cited by this paper
• Remodelling of high density lipoproteins by plasma factors.

  1999cited by this paper
• Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion*

  1997cited by this paper
• The Influence of Cholesteryl Ester Transfer Protein on the Composition, Size, and Structure of Spherical, Reconstituted High Density Lipoproteins (*)

  1995cited by this paper
• Interfacial properties of recombinant human cholesterol ester transfer protein.

  1994cited by this paper
• The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins.

  1994cited by this paper
• Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL.

  1992cited by this paper
• Lipids and risk of coronary heart disease. The Framingham Study.

  1992cited by this paper
• Rapid purification of human plasma lipid transfer proteins.

  1990cited by this paper
• Role of cholesteryl ester transfer protein (CETP) in the HDL conversion process as evidenced by using anti-CETP monoclonal antibodies.

  1990cited by this paper

• Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.

  2023cites this paper
• Fluorinated Benzyloxalamides: Glide Docking Pharmacophore Mapping Synthesis and In Vitro Evaluation as Potential Cholesteryl Ester Transfer Protein Inhibitors

  2022cites this paper
• Genetics of Cholesterol-Related Genes in Metabolic Syndrome: A Review of Current Evidence

  2022cites this paper
• Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans

  2022cites this paper
• Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib

  2021cites this paper
• Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib

  2021cites this paper
• Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters.

  2020cites this paper
• Present therapeutic role of cholesteryl ester transfer protein inhibitors

  2018cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib

  2018cites this paper
• Evacetrapib: Another CETP Inhibitor for Dyslipidemia With No Clinical Benefit

  2017cites this paper
• Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors.

  2017cites this paper
• Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys[S]

  2017cites this paper
• Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

  2016cites this paper
• Cholesteryl ester transfer between lipoproteins does not require a ternary tunnel complex with CETP.

  2016cites this paper
• Cholesteryl ester transfer protein inhibitors: challenges and perspectives

  2016cites this paper
• Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein

  2015cites this paper
• Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease

  2015cites this paper
• Dysfunctional high-density lipoproteins in children with chronic kidney disease.

  2015cites this paper
• Torcetrapib and Dalcetrapib Safety: Relevance of Preclinical In Vitro and In Vivo Models

  2015cites this paper
• Potential Signal Transduction Regulation by HDL of the β2-Adrenergic Receptor Pathway. Implications in Selected Pathological Situations.

  2015cites this paper
• Will Lipidation of ApoA1 through Interaction with ABCA1 at the Intestinal Level Affect the Protective Functions of HDL?

  2015cites this paper
• Key structural arrangements at the C-terminus domain of CETP suggest a potential mechanism for lipid-transfer activity.

  2014cites this paper
• Treatment of Low HDL-C Subjects with the CETP Modulator Dalcetrapib Increases Plasma Campesterol Only in Those Without ABCA1 and/or ApoA1 Mutations

  2014cites this paper
• The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial.

  2014cites this paper